Silver Oak Securities Incorporated Has $956,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Silver Oak Securities Incorporated raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 136.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,349 shares of the pharmaceutical company’s stock after purchasing an additional 1,355 shares during the period. Silver Oak Securities […]

Related Keywords

Zurcher Kantonalbank Zurich Cantonalbank ,Sanfordc Bernstein ,Ourania Tatsis ,Vertex Pharmaceuticals ,Cantor Fitzgerald ,Securities Exchange Commission ,Vertex Pharmaceuticals Incorporated ,Sherbrooke Park Advisers ,Silver Oak Securities Incorporated ,News Ratings For Vertex Pharmaceuticals Daily ,Canaccord Genuity Group ,Quarter For Vertex Pharmaceuticals ,Vertex Pharmaceuticals Price Performance ,Telos Capital Management Inc ,Vertex Pharmaceuticals Profile ,Nasdaq ,Free Report ,Oak Securities Incorporated ,Park Advisers ,Capital Management ,Kantonalbank Zurich Cantonalbank ,Genuity Group ,Get Free Report ,Exchange Commission ,Chairman Jeffrey ,Pharmaceuticals Incorporated ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,